Mississippi Hemoglobin A1c Screening Coverage Act; create and require health insurance coverage for.
The act explicitly prohibits costs such as deductibles, copayments, or coinsurance from being applied to these screenings, ensuring that individuals can access this essential health service without facing any barriers to care. Additionally, the bill mandates that the Department of Insurance will be responsible for ensuring compliance with the new coverage requirements among health insurance providers. Self-insured employer plans governed by ERISA are exempt from the bill, although the act encourages voluntary compliance to enhance health outcomes.
House Bill 1251, also known as the Mississippi Hemoglobin A1C Screening Coverage Act, aims to expand health insurance coverage in Mississippi by requiring all health insurance policies and plans to provide 100% coverage for hemoglobin A1C screenings as part of annual wellness exams, starting from July 1, 2025. This bill is designed to promote the early detection and management of diabetes and pre-diabetic conditions, thereby improving public health outcomes across the state. Hemoglobin A1C screening is crucial for determining blood glucose levels and diagnosing potential diabetes-related issues.
While proponents argue that this initiative will significantly contribute to public health by facilitating early diabetes detection, it may face opposition concerning costs to insurance providers and potential implications for premiums, particularly regarding how insurers may adjust plans to offset expenses. The clarity of the law around enforcement, particularly in administering penalties for non-compliance by insurers, can also be a topic of discussion as the state prepares to implement the act.